How much funding has Forth Therapeutics raised?

Forth Therapeutics has raised $4.7M in total funding, most recently a Seed round.

Who are Forth Therapeutics's investors?

Forth Therapeutics's investors include Sofinnova Partners.

When was Forth Therapeutics founded?

Forth Therapeutics was founded in 2025.

Where is Forth Therapeutics headquartered?

Forth Therapeutics is headquartered in Edinburgh, United Kingdom.

What industry is Forth Therapeutics in?

Forth Therapeutics operates in Biotech, Healthcare.

How many employees does Forth Therapeutics have?

Forth Therapeutics has 1-10 employees.

Forth Therapeutics

Edinburgh, United Kingdom · Founded 2025 · $4.7M raised

Biotech

Healthcare

Headquarters: Edinburgh
Employees: 1–10
Founded: 2025
Business Model: B2B

Website: forthtx.com
Total Funding: $4.7M
Last Round: $4.7M SeedMar 2025
Rounds: 1

About

Forth Therapeutics is a precision biotech company developing therapeutics that target the underlying mechanisms driving fibrotic and inflammatory diseases. The company was spun out of the University of Edinburgh in early 2025, built on pioneering research from Professor Neil Henderson, a world-renowned expert in liver fibrosis. Using multi-omic insights from patient-derived tissue samples — including single-cell and spatial genomics — Forth has built one of the largest single-cell human liver disease datasets in the world, which it uses to identify antifibrotic drug targets with high precision. Headquartered in Edinburgh and Cambridge, the company is led by CEO Alex Leech, a serial entrepreneur and partner at lead investor Sofinnova Partners.

Summary

Forth Therapeutics is a Biotech company based in Edinburgh, United Kingdom, founded in 2025. It has raised $4.7M in total across 1 round, most recently a $4.7M Seed round in Mar 2025. Investors include Sofinnova Partners.